Rivaroxaban in patients with mechanical heart valves: A pilot study
Patients with mechanical heart valves are still not eligible for treatment with direct oral anticoagulants (DOAC). We aimed to conduct a proof-of-principle study investigating the anti-Xa inhibitor rivaroxaban as antithrombotic treatment in patients with recent mechanical aortic valve replacement.
Source: Thrombosis Research - Category: Hematology Authors: Eva Roost, Alberto Weber, Lorenzo Alberio, Lars Englberger, David Reineke, Doroth ée Keller, Michael Nagler, Thierry Carrel Tags: Full Length Article Source Type: research
More News: Cardiology | Heart | Heart Valve Disease | Heart Valve Surgery | Heart Valves | Hematology | Study | Thrombosis